Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation naive children with transfusional iron overload

European Journal of Haematology, 03/27/2012

Deferasirox (DFX) is well tolerable and at least as effective as Desferrioxamine (DFO) to maintain safe serum ferritin levels and normal growth progression in chelation–naive children.

Print Article Summary